Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
| ▸ | AOC2 | O75106 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2379351 | 1.00 | TSHR (0.43) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL594776 | 0.86 | TSHR (0.43) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL27275039 | 0.84 | TSHR (0.42) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| Tromethamine SCHEMBL21440356 | 0.84 | KDM4E (0.39) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL28087225 | 0.82 | DRD2 (0.37) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL1168100 | 0.82 | MAPT (0.46) | MEN1KMT2ARAB9ACYP1A2KDM4E | |
| SCHEMBL27594718 | 0.82 | SMN1; SMN2 (0.41) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL2571438 | 0.82 | CA2 (0.38) | TSHRKMT2ASMN1; SMN2NPC1RAB9A | |
| SCHEMBL25438306 | 0.80 | TSHR (0.39) | TSHRMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL21851530 | 0.80 | TSHR (0.46) | TSHRMEN1KMT2ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296076-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | INV NYLON CHEMICALS AMERICAS, LLC | 2025-09-25 | — | — | US | claimed |
| EP-4499303-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | INVISTA Textiles (U.K.) Limited (GB) | 2025-02-05 | — | — | EP | claimed |
| WO-2023228077-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | INV NYLON CHEMICALS AMERICAS, LLC (US) | 2023-11-30 | — | — | WO | claimed |
| US-20250353945-A1 | REACTIVE RESINS BASED ON ETHYL METHACRYLATE | RÖHM GMBH (DE) | 2025-11-20 | — | — | US | disclosed |
| EP-4519336-A1 | TERMINALLY UNSATURATED (METH)ACRYLATE CROSSLINKERS AND USE THEREOF | Röhm GmbH (DE) | 2025-03-12 | — | — | EP | disclosed |
| EP-4168487-B1 | CURING OF REACTIVE RESINS USING UNSATURATED PEROXIDES AS INITIATOR AND ORGANIC PHOSPHITES AS ACCELERATORS | ROEHM GMBH (DE) | 2024-04-10 | — | — | EP | disclosed |
| WO-2023213708-A1 | TERMINALLY UNSATURATED (METH)ACRYLATE CROSSLINKERS AND USE THEREOF | RÖHM GMBH (DE) | 2023-11-09 | — | — | WO | disclosed |
| US-20230257619-A1 | Curing of reaction resins using unsaturated peroxides as initiators and organic phosphites as accelerators | RÖHM GMBH (DE) | 2023-08-17 | — | — | US | disclosed |
| EP-4168487-A1 | CURING OF REACTION RESINS, USING UNSATURATED PEROXIDES AS THE INITIATATOR AND ORGANIC PHOSPHITES AS THE ACCELERATOR | Röhm GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296076-A1 | MULTIDENTATE PHOSPHITE LIGANDS, CATALYTIC COMPOSITIONS CONTAINING SUCH LIGANDS, AND CATALYTIC PROCESSES UTILIZING SUCH CATALYTIC COMPOSITIONS | PHOSPHO1, PPA1, PNKP | TSHR 2871/4885MEN1 167/4885KMT2A 2998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.